Allogeneic B-cell concentrates
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic B-cell concentrates, covering 2014-03-26 to 2014-03-26. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]